FMBTD
ALDX icon

First Midwest Bank Trust Division’s Aldeyra Therapeutics ALDX Stock Holding History

First Midwest Bank Trust Division’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,750
Closed -$103K – 376
2021
Q3 		$103K Sell
11,750
-154,478
-93% -$1.42M 0.01% 363
2021
Q2 		$1.88M Buy
166,228
+103,897
+167% +$1.25M 0.25% 100
2021
Q1 		$740K Buy
+62,331
New +$718K 0.1% 194

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

First Midwest Bank Trust Division's ALDX Position: Q4 2021 in Review

First Midwest Bank Trust Division sold out of Aldeyra Therapeutics (ALDX) in Q4 2021, closing a stake of 11,750 shares — an estimated $103K sold.

First Midwest Bank Trust Division first reported a position in ALDX in Q1 2021 and held it in 3 quarters. The position peaked at $1.88M in Q2 2021. 115 funds tracked by Wall St. Rank hold ALDX as of Q4 2021.

  • First Midwest Bank Trust Division reported no remaining Aldeyra Therapeutics position as of Q4 2021 after selling out during the quarter.
  • First Midwest Bank Trust Division sold 11,750 Aldeyra Therapeutics shares in Q4 2021, an estimated $103K.
  • First Midwest Bank Trust Division first reported a position in Aldeyra Therapeutics in Q1 2021 and held it in 3 quarters.
  • First Midwest Bank Trust Division's Aldeyra Therapeutics position peaked at $1.88M in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.